We isolated and purified to homogeneity a caseinolytic protease from a Nocardia brasiliensis cell extract. Preparative polyacrylamide gel electrophoresis and electroelution were employed for purification. This purified protease was injected in BALB/c mice and induced IgM and IgG anti-protease antibodies. Active immunization of mice with this protease prevented mycetoma development in experimentally infected animals. Passive immunization with hyperimmune sera containing a high anti-protease antibody titer conferred partial but transient protection when collected 30 days after donor's immunization. The protective effect of hyperimmune sera was lost when obtained from donors after 60 days from their immunization despite its higher anti-protease antibody concentration. Cytokines are good candidates to explain these findings.
Introduction
Mycetoma is a chronic infectious disease that may be produced by fungi or by bacteria. Pinoy in 1913 named eumycetoma those cases, produced by fungi and actinomycetoma, where the etiologic agent has been a bacterium [1] . In Mexico more than 90% of mycetoma cases are produced by bacteria such as Nocardia brasiliensis. However, Actinomadura madurae, Streptomyces somaliensis, Nocardia asteroides, Actinomadura pelletieri and some other microorganisms may occasionally be isolated [2] . These actinomycetes live as saprophytes in soil and enter the skin through traumatic inoculation. They a¡ect skin, subcutaneous tissues and later may extend to muscle, bones and adjacent organs [3] . This chronic infection is characterized by progressive in£ammation with abscess, ulcers and ¢s-tulae, which drain a serous liquid containing microcolonies of the etiologic agent, the so called 'granules'. Severe mycetoma cases due to N. brasiliensis may produce osteolytic lesions that are completely healed after successful antimicrobial treatment [3] . We previously identi¢ed three immunodominant antigens recognized by sera from active mycetoma patients in a Western blot assay [4] . Using simple physicochemical techniques we isolated and puri¢ed two of these immunodominant antigens, the P24 and P61 from a cell extract of N. brasiliensis [5] . The puri¢ed antigen P24 was used to set up an enzyme-linked immunoadsorbent assay (ELISA), which helped to demonstrate a strong IgG anti-P24 antibody response. In the same study a good clinical correlation was found between active infection in mycetoma patients and high anti-P24 antibody concentration [6] . BALB/c mice experimentally infected with a N. brasiliensis produced a strong antibody titer, these antibodies reacting with immunodominant antigens P61 and P24 as in mycetoma patients [7] . The role of circulating anti-Nocardia antibodies in host protection is not clear, but some studies have suggested that they play no role in protection and may even worsen the lesions [8, 9] . Passive humoral immunity in experimental mice was shown to prevent the N. brasiliensis infection. However, hyperimmune sera from spontaneously cured animals or from immunized rabbits had no e¡ect, suggesting that other humoral factors are involved in protection [10] . Mechanisms of pathogenicity in mycetoma due to N. brasiliensis are partially known. In 1992 we identi¢ed three intracellular proteases that reacted with circulating antibodies present in sera from mycetoma patients and suggested their possible participation in tissue damage [11] .
In the presented study we isolated and puri¢ed a N. brasiliensis protease to homogeneity. Biophysical properties such as molecular mass, isoelectric point and catalytic class were identi¢ed. We also studied the immunogenicity and demonstrated the protective role of active and passive immunization in prevention of mycetoma development in BALB/c mice.
Materials and methods

Animals
We used 9^12-week-old male and female BALB/c mice. These animals were derived from the colony donated by Dr. Carl Hansen (Small Animal Section, Veterinary Resources Branch, NIH, Bethesda, MD, USA) and maintained with rodent food and water ad libitum.
Bacterial strain
N. brasiliensis strain HUJEG-1 was used in this study. This bacterium was isolated from a human actinomycetoma patient attending the Dr. Jose ¤ E. Gonza ¤lez University Hospital in Monterrey, Mexico. June Brown at the Actinomycete Laboratory at the CDC, Atlanta, GA, USA, recon¢rmed identi¢cation of this strain. This strain is registered in the ATCC with number 700358 and is maintained in our laboratory by subculturing on Sabouraud agar.
Bacterial crude extract
The technique to obtain a N. brasiliensis cell extract has been published [5, 7] and is summarized here. Unicellular N. brasiliensis suspensions were used to inoculate 40-l Erlenmeyer £asks containing 150 ml of brain-heart infusion media and incubated at 37 ‡C for 7 days in stationary conditions. Bacterial mass was washed with distilled water and defatted with ethanol:ethylic-ether (1:1). After drying, cells were ground with glass powder. A bu¡er solution made of 0.01 M Tris^HCl, pH 7.4, with 0.01 M magnesium acetate was used to suspend the ground cells. The suspension was magnetically stirred for 12 h at 4 ‡C and centrifuged at 200Ug for 30 min, glass and cell debris were removed and the supernatant was sterilized by membrane ¢ltration at 0.22 Wm. Protein content was determined using the Bradford technique [12] . The crude cell extract (CCE) was lyophilized and stored at 370 ‡C.
Protease isolation, puri¢cation and electroelution
The puri¢cation process consisted of three steps: ¢rst we used ion-exchange chromatography in a DEAE-cellulose (Sigma) column (11.0U2.7 cm) equilibrated with 0.1 M Tris^HCl, pH 6.5. We applied 300 mg of CCE to the column and collected 2-ml fractions eluted with 1 M NaCl. Individual fractions were dialyzed against distilled water, lyophilized and frozen at 370 ‡C. An aliquot of eluted and retained proteins was analyzed in sodium dodecyl sulfate^polyacrylamide gel electrophoresis (SDSP AGE) and shown in Fig. 2 . A non-denaturing PAGE was used as a second step for puri¢cation. The isolated protease in the ion-exchange chromatography was resolved in 14.2U10U0.3-cm linear gels, prepared as follows : 8% T, 2.7% C polyacrylamide was used as resolving gel and a 4% as stacking gel. The discontinuous bu¡ering system according to Laemmli was used [13] . A 3.5-mg protease aliquot was mixed with 2U sample bu¡er made of 0.125 M Tris^HCl, pH 6.8, 50% saccharose and 0.0005% bromophenol blue. Electrophoresis was run at 80 V for packing and 150 V for resolving until the dye reached the front. One 0.5-cm gel slice was cut and stained with Coomassie blue R-250.
The third puri¢cation step consisted of eluting protease from gels. The slices from preparative polyacrylamide gels containing the protease were cut into small pieces, electroeluted (Electroelutor model 422, Bio-Rad Laboratories, Richmond, CA, USA) and concentrated. A dialysis membrane with molecular cuto¡ of 12^14 kDa (Sigma) was used to concentrate the eluted enzyme. The electroelution was carried out at 10 mA for 2.5 h at 4 ‡C and the protease removed from the cathode chamber. Purity of protease was assessed by quantitating its speci¢c activity after each puri¢cation step and by SDS^PAGE.
Quanti¢cation of proteolytic activity
The proteolytic activity of puri¢ed protease was determined by the McLaughlin and Faubert technique [14] with modi¢cations: 50 Wl of puri¢ed electroeluted protease was mixed with 50 Wl of 0.1 M Tris^HCl, 0.01 M CaCl 2 , pH 7.4, in a water bath at 37 ‡C. One hundred microliter of azocasein substrate (10 mg ml 31 ) was added and incubated for 10 min. Reaction was stopped with 200 Wl of a 5% trichloroacetic acid solution (w/v). Tubes were centrifuged at 7700Ug for 5 min (Microcentrifuge Eppendorf, model 5415). After centrifugation 150 Wl of supernatant was mixed with 350 Wl of 0.5 N NaOH, absorbance was recorded at 440 nm by spectrophotometry (DU-6, Beckman Instruments). Enzymatic activity was calculated in units according to the equation: activity (U ml 31 ) = A 440 U60/ 1.6(t), where t is incubation time in minutes and 1 U is the amount of protease needed to hydrolyze 1 mg of azocasein substrate in 1 h at a given pH. Speci¢c activity was calcu-lated dividing enzymatic activity in U ml 31 by mg ml 31 of used protease [15] .
Catalytic class identi¢cation with inhibitors
We used enzymatic inhibitors to identify the catalytic class of the puri¢ed protease of N. brasiliensis. The standard protocol was used [16] with modi¢cations as described here: 0.645 U mg 31 of protease was incubated for 15 m at 37 ‡C in several Eppendorf microcentrifuge tubes with 0.2, 2 and 20 mM phenylmethylsulfonyl £uo-ride (PMSF), 0.5, 5 and 50 mM ethylenediamine tetraacetic acid (EDTA), 0.1, 1 and 10 mM iodoacetic acid and 0.2, 2 and 20 mM 1,10-phenanthroline. After incubation, azocasein was added as substrate and the procedure described above for quanti¢cation of proteolytic activity was completed. Results are expressed as percentage of inhibition. Duplicates of PMSF tubes were also incubated with 10 mM 2-mercaptoethanol.
Determination of molecular mass of puri¢ed protease
To determine the molecular mass of puri¢ed protease we used gel ¢ltration chromatography under native conditions in a G-100 Sephadex column (20.8U2.3 cm). Protease sample and molecular mass markers (MW GF-70, Sigma) were dissolved in 50 mM Tris^HCl, pH 7.5. Fractions of 2 ml were collected and their absorbance at 280 nm was obtained to calculate the elution volume (V e ). The proteolytic activity in each fraction was determined as described above. SDS^PAGE was also used to determine the molecular mass of puri¢ed protease by using denaturing conditions. We prepared 5% T, 2.7% C polyacrylamide as stacking gel and 10^18% T as resolving gel. The polyacrylamide gel gradient was prepared (Gradient Former, Bio-Rad Laboratories, Richmond, CA, USA) and electrophoresis was carried out in the Mini Protean II (Bio-Rad Laboratories, Richmond, CA, USA). The discontinuous bu¡ering system of Laemmli was used with the running bu¡er made of 125 mM Tris^HCl, 192 mM glycine, 0.1% SDS. The 4U sample bu¡er contained 125 mM Tris^HCl, pH 6.8, 10% SDS, 10% 2-mercaptoethanol, 50% saccharose and bromophenol blue. The protease and the sample bu¡er were boiled for 2 min and the electrophoresis was resolved at 150 V until the dye reached the front. Molecular mass markers included: K-lactalbumin (14 200 Da); trypsin soybean inhibitor (20 100 Da); trypsinogen (24 000 Da); carbonic anhydrase (29 000 Da); glyceraldehyde-3-phosphate dehydrogenase (36 000 Da); bovine serum albumin (66 000 Da); ovalbumin (45 000 Da). Gels were stained with silver nitrate (Bio-Rad Laboratories, Richmond, CA, USA) or with Coomassie blue R-250.
Analytic isoelectric focusing
To determine the protease isoelectric point (pI), we used a published procedure [17] brie£y summarized here: 5% T, 2.9% C polyacrylamide gel with a pH gradient from 3 to 10 (Ampholine, Sigma) was used in a Multiphor II unit (LKB). Anode solution was 1 M H 3 PO 4 and 1 M NaOH was used as cathode solution. An isoelectric focusing chamber was prepared according to the manufacturer's instructions and run at 20 W for 3 h. The pI markers (IEF, Sigma) included: Aspergillus oryzae amyloglycosidase (pI 3.55); soybean trypsin inhibitor (pI 4.55); L-lactoglobulin A (pI 5.13); carbonic anhydrase (pI 5.65); horse myoglobin (pI 6.76 and 7.16); lactic dehydrogenase (pI 8.3); and trypsinogen (pI 9.30). Results were obtained by measuring the migration distance (cm) from anode and plotted against pI of each marker.
ELISA for anti-protease antibodies
An ELISA was set up to quantitate anti-protease antibodies as described elsewhere [18] with the following modi¢cations: £at bottom, 96-well, polystyrene plates (Costar) were used. Puri¢ed protease at a concentration of 0.5 Wg per well, dissolved in 200 Wl of 0.14 M acetate bu¡er, pH 5, was incubated at 4 ‡C overnight. After three washings with 0.15 M phosphate-bu¡ered saline (PBS) containing 1:1000 Tween 20 (PBS-T), 200 Wl of PBS-T with 5% skimmed milk was used as blocking solution for 2 h at 37 ‡C. We washed again with PBS-T, and 1:50 diluted mouse serum was added. Plates were incubated at 37 ‡C for 1 h and washed ¢ve times, and a peroxidase-conjugated goat anti-mouse immunoglobulin (Sigma) diluted 1:1000 was added. The chromogen substrate solution was composed of o-phenylenediamine and hydrogen peroxide; 1 N sulfuric acid was added to stop the reaction. The absorbance A 492 was read with a semi-automatic ELISA plate reader. Hyperimmune sera from mice immunized four times with protease emulsi¢ed with incomplete Freund's adjuvant (IFA) were used as positive control. a Total protein content (Bradford) . b Puri¢cation grade = speci¢c activity in the actual puri¢cation step divided by speci¢c activity in previous step.
Immunogenicity of puri¢ed protease
Twelve BALB/c mice were either injected subcutaneously with 10 Wg of puri¢ed protease in saline solution or emulsi¢ed with IFA. We collected blood samples 15, 30 and 60 days after immunization and before injecting them again with 3 Wg of protease with or without adjuvant. Two weeks later the animals were bled again. Antiprotease antibodies determination was made in the ELISA assay as described above. Pooled sera were heat-inactivated at 56 ‡C for 30 min and sterilized by membrane ¢ltration with 0.22-Wm ¢lters and frozen at 370 ‡C until used.
E¡ect of active and passive immunization with protease
The e¡ect of active immunization with protease was investigated in eight BALB/c mice groups immunized with 10 Wg of protease alone, or emulsi¢ed with IFA. A control group received saline solution emulsi¢ed with the same adjuvant. Fifteen days later both groups have been re-immunized with either 3 Wg of emulsi¢ed protease or saline solution. All mice were then infected 2 weeks later with 50 Wl of a N. brasiliensis ATCC 700358 strain containing 5U10 6 colony forming units (CFU) in the left rear footpad and observed daily for mycetoma signs. To investigate the role of passive immunization in mycetoma development, we used naive recipient BALB/c mice. These groups of animals were injected intramuscularly with 100 Wl of hyperimmune sera with high anti-protease antibody titer or with sera from mice injected only with IFA. All animals were then infected with the N. brasiliensis ATCC 700358 strain (5U10 6 CFU) and received two additional sera injections at 48 and 96 h post-infection. The mycetoma control group consisted of BALB/c mice that were infected at the same time but received neither active nor passive immunization. Severity of in£ammation was quanti¢ed in centimeters lengthwise.
Results
Protease isolation
A summary of techniques used for isolation and puri¢-cation of N. brasiliensis protease is shown in Fig. 1 . The complex composition of the CCE is shown in lane 2 of Fig. 2 . In lane 3 of this ¢gure we show that more than 90% of protein bands demonstrated in lane 2 were adsorbed to the ion-exchanger at pH 6.5. Lane 4 shows the electroeluted protease.
Protease puri¢cation
The speci¢c activity of isolated protease is presented in Table 1 , the N. brasiliensis cell extract containing 1.8 U mg 31 of total protein. After the ¢rst puri¢cation step in the DEAE-cellulose ion-exchanger, speci¢c activity was increased to 5.7 U mg 31 , which means 3.1 puri¢cation grade. After the third step of puri¢cation in the preparative polyacrylamide gels, the electroeluted protease had a speci¢c activity of 109.7 U mg 31 of protein, giving a 60.9 puri¢cation grade. This puri¢ed protease was used to investigate the biophysical properties and its immunogenicity.
Biophysical properties of puri¢ed protease
Molecular size exclusion chromatography with a G-100 Table 2 Catalytic classi¢cation of N. brasiliensis protease using enzymatic inhibitors Sephadex column was used to calculate the molecular mass of the puri¢ed protease, giving a molecular mass of 42 kDa under native conditions. However, the same puri¢ed protease showed a smaller molecular mass of 38 kDa when treated with SDS, 2-mercaptoethanol and boiling. This data were obtained from SDS^PAGE by determining the mobility relative to molecular mass markers.
Isoelectric point
Puri¢ed protease analyzed by isoelectric focusing showed a pI of 5.28.
Protease catalytic classi¢cation
Using enzymatic inhibitors, we found that the puri¢ed protease's active site is serine-dependent as suggested by the 58% inhibitory e¡ect produced by PMSF. In Table 2 we show that inhibitory e¡ect of PMSF was not reversed by 2-mercaptoethanol. In contrast, EDTA and 1,10-phenanthroline, two well-known metalloprotease inhibitors, had no e¡ect on puri¢ed protease of N. brasiliensis. Iodoacetic acid, a cysteine-dependent enzymatic inhibitor, had no e¡ect on protease activity as shown in Table 2 .
Immunogenicity of N. brasiliensis protease
BALB/c mice immunized with the puri¢ed protease alone or emulsi¢ed with IFA produced anti-protease antibodies. The isotype of speci¢c anti-protease antibodies was IgM the ¢rst 2 weeks of response, and IgG1 and IgG2a in the secondary response (data not shown). The A 492 of nonimmunized mice was 0.047. That increased to 0.586 after 30 days of immunization with non-emulsi¢ed protease. The anti-protease antibody titer was higher in mice injected with protease emulsi¢ed with IFA. In this case the A 492 increased from 0.029 to 1.2 after 30 days of immunization as shown in Table 3 .
The role of anti-protease antibodies in N. brasiliensis infection
To investigate the role of circulating anti-protease antibodies, we used active immunization with protease alone or emulsi¢ed with IFA as described above. Results presented in Fig. 3 demonstrate a di¡erence in severity of infection between immunized and non-immunized animals. The protected mice had no mycetoma even 150 days after infection. A control group immunized with IFA but no Fig. 2 . Analytical SDS^PAGE in a 10^18% gradient. Lanes: 1, molecular mass markers ; 2, CCE; 3, proteins non-adsorbed to DEAE-cellulose ; 4, protease electroeluted from non-denaturing PAGE. Gels were stained with Coomassie blue followed by silver stain.
-
antigen developed severe mycetoma compared with another control group that was only infected. Statistical analysis of in£ammation quantitated in centimeters was carried out with Student's t-test (P 6 0.02).
E¡ect of passive immunization in N. brasiliensis infection
To con¢rm the protective role of anti-protease antibodies against N. brasiliensis infection, we transferred hyperimmune sera. The sera used in these experiments were obtained from mice immunized with protease alone or with protease and IFA. The recipient mice were then infected with the same bacterial strain, N. brasiliensis (ATCC 700358). Sera from BALB/c mice donors contained a high anti-protease antibody titer as shown by its A 492 value in ELISA and conferred more than 90% protection against mycetoma infection. Only one mouse out of seven developed mycetoma 90 days after infection. The recipient group transferred with sera from proteaseÎ FA was protected for 30 days but 28% and 42.5% of them developed mycetoma 2 and 3 months after infection. Speci¢city of this protective e¡ect was further investigated by transferring sera from mice immunized with IFA but no antigen. The recipients were partially protected for 30 days but others presented mycetoma 2 or 3 months later exactly as the protease^IFA group shown in Table 4 . In other experiments we used high anti-protease antibody titer sera collected 60 days after donor's immunization, but conferred no protection against mycetoma as compared to the hyperimmune sera collected 30 days after immunization. Fig. 4 presents a photograph of a BALB/c footpad with a mycetoma lesion from the non-protected group.
Discussion
In the present research we puri¢ed to homogeneity a protease from a N. brasiliensis cell extract. This puri¢ed protease is di¡erent from the extracellular enzyme described by Zlotnik and Buckley [19] . The molecular mass of the protease described here is 38 kDa under denaturing conditions while they reported a 35-kDa enzyme. In addition, they classi¢ed the protease as zinc metalloprotease but we found no e¡ect from either EDTA or 1,10-phenanthroline. In contrast, in our experiments, PMSF decreased the proteolytic activity, which was not reversed by 2-mercaptoethanol, thus, strongly suggesting that this protease has a serine-dependent catalytic site. We previously identi¢ed three intracellular proteases from a N. brasiliensis CCE; one of them was also inhibited by EDTA and may be related to the protease described by Zlotnik [11] . Di¡erent bacterial culture conditions used by researchers above may explain the presence of metallopro- teases, since media components may induce enzymes. Tsuboi and co-workers identi¢ed serine proteases in culture ¢ltrates of N. asteroides and found a correlation between severe pathogenicity and high protease production [20] . However, presence of caseinolytic activity has been used as a criterion to di¡erentiate between N. asteroides and N. brasiliensis; Nocardia isolates lacking this proteolytic activity are classi¢ed as N. asteroides [21] . Additional studies of amino acid composition or cloned gene that encodes the protease described here will be of great help in species identi¢cation and taxonomy of N. brasiliensis. The role of protease in bone destruction could be explored in more detail because it may be involved in tissue damage [11] . N. brasiliensis protease is immunogenic in humans su¡er-ing from actinomycetoma, but the anti-protease antibody titer is high in cured patients and very low in actively infected patients. The protease described here is immunogenic in BALB/c mice as demonstrated by the induced antibody response. The role of anti-protease antibodies in N. brasiliensis infections had not been studied before.
In this study we demonstrate that active immunization with protease alone or emulsi¢ed with IFA protected BALB/c mice from developing mycetoma. This protective e¡ect was similar in animals immunized with emulsi¢ed antigen as shown in Fig. 3 . To further support the notion of protection by anti-protease antibodies, we injected hyperimmune sera into naive recipients and observed only partial and temporary protection. However, this partial protection was also seen in animals that received sera from IFA-injected mice. These sera contained no anti-protease antibodies and yet conferred partial protection to recipients. This suggests that other humoral factors, not related to antibodies, were responsible for the protective e¡ect. Moreover, the partial protection in passively immunized mice was not present in animals that have been transferred with hyperimmune sera collected after 60 days of donor immunization. Furthermore, the sera from this donor group contained a higher anti-protease antibody titer as tested by ELISA assay (Table 3) . Based on these ¢ndings, we conclude that active immunization with protease prevents mycetoma and that anti-protease sera only induce transient protection against infection. The protective e¡ect reported here is not strictly antigen-speci¢c but is in part induced by antigen or by adjuvant stimulation. Candidate mediators for this humoral e¡ect are cytokines. Similar ¢ndings were reported in 1996 in where rabbit hyperimmune sera with great anti-N. brasiliensis titers did not confer protection to recipient mice [10] . The data reported here, that hyperimmune sera, collected 60 days after donor immunization, despite its high antibody titer, do not confer protection, further support the possible role of cytokines in preventing mycetoma. More studies are needed to identify the responsible mediators of the protective e¡ect described here; that information will be of help in designing an e¡ective vaccine to prevent infection by N. brasiliensis.
